In animal models of schizophrenia, oxytocin seems to decrease dopaminergic activity, for example, in the nucleus accumbens, an effect that has also been demonstrated in response to drugs such as cocaine, methamphetamine, and phencyclidine [175]. The gene discussed is OXT; the disease is schizophrenia.